ATE353332T1 - Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren - Google Patents

Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren

Info

Publication number
ATE353332T1
ATE353332T1 AT02731063T AT02731063T ATE353332T1 AT E353332 T1 ATE353332 T1 AT E353332T1 AT 02731063 T AT02731063 T AT 02731063T AT 02731063 T AT02731063 T AT 02731063T AT E353332 T1 ATE353332 T1 AT E353332T1
Authority
AT
Austria
Prior art keywords
nicotinic acetylcholine
acetylcholine receptors
suitable ligand
new therapy
therapy
Prior art date
Application number
AT02731063T
Other languages
English (en)
Inventor
Eifion Phillips
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE353332T1 publication Critical patent/ATE353332T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
AT02731063T 2001-06-01 2002-05-29 Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren ATE353332T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29520601P 2001-06-01 2001-06-01

Publications (1)

Publication Number Publication Date
ATE353332T1 true ATE353332T1 (de) 2007-02-15

Family

ID=23136711

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02731063T ATE353332T1 (de) 2001-06-01 2002-05-29 Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren

Country Status (19)

Country Link
EP (1) EP1397366B1 (de)
JP (1) JP2004532877A (de)
KR (1) KR20040003021A (de)
CN (1) CN1294136C (de)
AT (1) ATE353332T1 (de)
BR (1) BR0210075A (de)
CA (1) CA2455341A1 (de)
DE (1) DE60218032T2 (de)
DK (1) DK1397366T3 (de)
ES (1) ES2280538T3 (de)
HK (1) HK1063787A1 (de)
IL (1) IL158735A0 (de)
MX (1) MXPA03010996A (de)
NO (1) NO20035333D0 (de)
NZ (1) NZ529426A (de)
PT (1) PT1397366E (de)
SI (1) SI1397366T1 (de)
WO (1) WO2002096912A1 (de)
ZA (1) ZA200308779B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
DE60328010D1 (de) 2002-04-18 2009-07-30 Astrazeneca Ab Heterocyclische verbindungen
CA2482311C (en) * 2002-04-18 2009-12-08 Astrazeneca Ab Furyl compounds
JP4511196B2 (ja) * 2002-04-18 2010-07-28 アストラゼネカ・アクチエボラーグ チエニル化合物
JP4855264B2 (ja) 2003-10-21 2012-01-18 アストラゼネカ・アクチエボラーグ スピロフロピリジンアリール誘導体
TW200813067A (en) * 2006-05-17 2008-03-16 Astrazeneca Ab Nicotinic acetylcholine receptor ligands
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
EA201001889A1 (ru) 2008-06-20 2011-08-30 Астразенека Аб Производные дибензотиазепина и их применение
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
ES2746850T3 (es) 2010-05-17 2020-03-09 Forum Pharmaceuticals Inc Formulaciones farmacéuticas que comprenden formas cristalinas de clorhidrato de (R)-7-cloro-N-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida monohidratado
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
MX358512B (es) 2012-05-08 2018-08-24 Forum Pharmaceuticals Inc Uso de (r)-7cloro-n-(quinuclidin-3-il) benzo[b] tiofeno-2-carboxamida o una sal farmacéuticamente aceptable de la misma para preparar una composición farmacéutica en el tratamiento de una disfunción cognitiva.
GB201209587D0 (en) 2012-05-30 2012-07-11 Takeda Pharmaceutical Therapeutic compounds
WO2014122474A1 (en) 2013-02-07 2014-08-14 Takeda Pharmaceutical Company Limited Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
CA2914263C (en) 2013-06-21 2021-05-18 Takeda Pharmaceutical Company Limited 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
GB201314286D0 (en) 2013-08-08 2013-09-25 Takeda Pharmaceutical Therapeutic Compounds
GB201318222D0 (en) 2013-10-15 2013-11-27 Takeda Pharmaceutical Novel compounds
GB201320905D0 (en) 2013-11-27 2014-01-08 Takeda Pharmaceutical Therapeutic compounds
TW201613864A (en) 2014-02-20 2016-04-16 Takeda Pharmaceutical Novel compounds
GB201616839D0 (en) 2016-10-04 2016-11-16 Takeda Pharmaceutical Company Limited Therapeutic compounds
GB201619514D0 (en) 2016-11-18 2017-01-04 Takeda Pharmaceuticals Co Novel compounds
JP2021138648A (ja) 2020-03-04 2021-09-16 武田薬品工業株式会社 経口固形製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002500652A (ja) * 1997-05-30 2002-01-08 ニューロサーアチ・アクティーゼルスカブ スピロ−キヌクリジン誘導体、その製造方法及びその使用方法
AR013184A1 (es) * 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) * 1999-01-15 1999-01-15 Astra Ab New compounds

Also Published As

Publication number Publication date
MXPA03010996A (es) 2004-02-27
BR0210075A (pt) 2004-08-17
NZ529426A (en) 2005-07-29
CN1294136C (zh) 2007-01-10
ZA200308779B (en) 2005-02-11
EP1397366B1 (de) 2007-02-07
ES2280538T3 (es) 2007-09-16
DE60218032T2 (de) 2007-08-16
WO2002096912A1 (en) 2002-12-05
PT1397366E (pt) 2007-04-30
NO20035333D0 (no) 2003-11-28
CN1512995A (zh) 2004-07-14
KR20040003021A (ko) 2004-01-07
EP1397366A1 (de) 2004-03-17
HK1063787A1 (en) 2005-01-14
CA2455341A1 (en) 2002-12-05
SI1397366T1 (sl) 2007-06-30
IL158735A0 (en) 2004-05-12
JP2004532877A (ja) 2004-10-28
DK1397366T3 (da) 2007-05-07
DE60218032D1 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
ATE353332T1 (de) Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren
ATE417049T1 (de) Biaryldiazabicycloalkanamide als nicotinische acetylcholinagonisten
MX2007006743A (es) Ligandos del receptor de acetilcolina nicotinica.
CY1111867T1 (el) Ενωση ενεργοποιησης ppar και φαρμακευτικη συνθεση που περιεχει αυτη
CY1109063T1 (el) Υποκατεστημενες 2-θειο-3,5-δικυανο-4-φαινυλο-6-αμινοπυριδινες και χρηση αυτων
DE60142355D1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
CY1113578T1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
DE60225341D1 (de) Neue 1,2,4-triazolverbindung
BR0100245B1 (pt) mÁquina em espiral (scroll).
BG106103A (en) Estrogen receptor-beta-ligands
DE60210785D1 (de) Fungizide mischung, die arylamidinderivate enthält
NO20042260L (no) Hoy hastighets, ikke samtidig kontrollert database
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
IS5888A (is) Efnameðferð við krabbameini með asetýldínalíni blönduðu gemsítabíni, kapesítabíni eða sisplatíni
NO20023840D0 (no) Reversert flyt stator ventilasjonssystem for superledende synkron maskin
RS52315B (en) DIARYLMETHYL PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE
CY1106579T1 (el) Μεθοδος για την παρασκευη συμπλοκων 1,2-διαμινοκυκλοεξανιου-δισθενους πλατινης
EP1568432A3 (de) Gehrungssäge
TR200700266T1 (tr) Bir soğutucu.
BR0205223B1 (pt) máquina ferramenta portátil.
AR027349A1 (es) Derivados de amidas heterociclicas
MXPA05012297A (es) Indazol que tiene actividad analgesica.
TR200603433T1 (tr) Bir soğutucu

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1397366

Country of ref document: EP

REN Ceased due to non-payment of the annual fee